News

Sheba doctors delivered the baby via emergency C-section in a specially designed room while the mother was hooked up to a ventilator.

Israeli medical facilities, hospitals, and organizations partner with national and international centers to acquire and manufacture medical equipment for treating and preventing the spread of COVID-19.

Presently, there are few and limited treatments available for patients infected with COVIDd-19, and all of these treatments are unproven and experimental. The study on Kevzara marks Israel’s first clinical research trial to identify an effective medical treatment.

While millions of people worldwide are battling against COVID-19, fortunately, the vast majority of patients who get infected will overcome the disease and survive.

The current pandemic poses a variety of new challenges to all healthcare professionals and facilities, including clinicians and researchers. In response, governments, including that of Israel, have enlisted high tech companies to assist in the battle against Covid-19.

On April 1, the first patient who recovered from Covid-19 donated plasma at the Magen David Adom (MDA) Blood Services Center at Sheba Medical Center.

Introducing Sheba's Critical Care Corona Unit The head of Sheba Medical Center's Infectious Disease unit, Professor Gili Regev-Yochay, speaks with Steve Walz, our international spokesperson, about Sheba's new Critical Care Corona Unit (CCCU) underground complex.

A compact blood analyzer developed by an Israeli blood testing startup has been implemented to support the healthcare management of coronavirus-infected patients.

Approximately two months after coronavirus COVID-19 broke out in China, the country has almost succeeded in halting the epidemic.